Terms ending in 2033
Every in-force patent on Roche Diagnostics GmbH's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,720,496 | Device, Kit, And Method For Filling a Flexible Reservoir Container In A Negative Pressure Chamber In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| US 11,419,790 | Automatic Device for Transferring Fluid In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| US 9,316,642 | Soluble Immunoreactive Treponema Pallidum TPN47 Antigens In force · High confidence | Roche Diagnostics Operations, Inc. | In force | High confidence | |
| US 9,222,951 | Calibration Method for the Prospective Calibration of Measuring Equipment In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| US 9,945,787 | Increasing the Usable Dynamic Range in Photometry In force · High confidence | Roche Diagnostics Operations, Inc. | In force | High confidence | |
| US 9,248,230 | Sensor Device For Use in a Medical Fluid Delivery System In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| US 8,770,482 | Apparatus and Method to Administer and Manage an Intelligent Base Unit for a Handheld Medical Device In force · High confidence | Roche Operations Ltd. | In force | High confidence | |
| US 10,302,657 | Dynamic of SFLT-1 or Endoglin/Plgf Ratio as an Indicator for Imminent Preeclampsia And/Or Hellp Syndrome In force · High confidence | Roche Diagnostics Operations, Inc. | In force | High confidence | |
| US 12,352,762 | DYNAMIC OF SFLT-1 OR ENDOGLiN/PIGF RATIO AS AN INDICATOR FOR IMMINENT PREECLAMPSIA AND/OR HELLP SYNDROME In force · High confidence | Roche Diagnostics Operations, Inc. | In force | High confidence | |
| US 9,573,761 | Analytical System for Examining a Body Fluid and Method for the Operation of an Analytical System In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| 82 more term ends in 2033 · Pro | |||||
10 of 92 patents shown. Soonest term end first, then patent number.
Pro members see all 92.
2 of these are in force and held by Roche Diagnostics GmbH.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.